Clinical Trials for Frantz Viral Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Frantz Viral Therapeutics

Clinical Trials (4)

NCT06206564
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
PHASE2Recruiting
48 participants
Started: Jan 12, 2024 · Completed: Dec 31, 2026
4 conditions3 sponsors2 locations
NCT06075264
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
PHASE2Recruiting
27 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2027
13 conditions2 sponsors5 locations
NCT05555862
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
PHASE2Active, not recruiting
17 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2026
6 conditions5 sponsors2 locations
NCT04098744
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
PHASE2Recruiting
78 participants
Started: Sep 9, 2020 · Completed: Dec 31, 2026
5 conditions7 sponsors7 locations